Your browser doesn't support javascript.
loading
A randomized phase 3 trial of zanubrutinib vs ibrutinib in symptomatic Waldenström macroglobulinemia: the ASPEN study.
Tam, Constantine S; Opat, Stephen; D'Sa, Shirley; Jurczak, Wojciech; Lee, Hui-Peng; Cull, Gavin; Owen, Roger G; Marlton, Paula; Wahlin, Björn E; Sanz, Ramón Garcia; McCarthy, Helen; Mulligan, Stephen; Tedeschi, Alessandra; Castillo, Jorge J; Czyz, Jaroslaw; Fernández de Larrea, Carlos; Belada, David; Libby, Edward; Matous, Jeffrey V; Motta, Marina; Siddiqi, Tanya; Tani, Monica; Trneny, Marek; Minnema, Monique C; Buske, Christian; Leblond, Veronique; Trotman, Judith; Chan, Wai Y; Schneider, Jingjing; Ro, Sunhee; Cohen, Aileen; Huang, Jane; Dimopoulos, Meletios.
Affiliation
  • Tam CS; Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.
  • Opat S; St Vincent's Hospital, Fitzroy, VIC, Australia.
  • D'Sa S; Department of Medicine, University of Melbourne, Parkville, VIC, Australia.
  • Jurczak W; Royal Melbourne Hospital, Parkville, VIC, Australia.
  • Lee HP; Monash Health, Clayton, VIC, Australia.
  • Cull G; Clinical Haematology Unit, Monash University, Clayton, VIC, Australia.
  • Owen RG; University College London Hospital Foundation Trust, London, United Kingdom.
  • Marlton P; Maria Sklodowska-Curie National Institute of Oncology, Krakow, Poland.
  • Wahlin BE; Flinders Medical Centre, Adelaide, SA, Australia.
  • Sanz RG; Sir Charles Gairdner Hospital, Perth, WA, Australia.
  • McCarthy H; Department of Lymphoma/Myeloma, University of Western Australia, Perth, WA, Australia.
  • Mulligan S; St James's University Hospital, Leeds, United Kingdom.
  • Tedeschi A; Department of Haematology, Princess Alexandra Hospital, Brisbane, QLD, Australia.
  • Castillo JJ; School of Medicine, University of Queensland, Brisbane, QLD, Australia.
  • Czyz J; Unit of Hematology, Department of Medicine, Karolinska Universitetssjukhuset-Karolinska Institutet, Stockholm, Sweden.
  • Fernández de Larrea C; Hospital Universitario de Salamanca, Salamanca, Spain.
  • Belada D; Royal Bournemouth and Christchurch Hospital, Bournemouth, United Kingdom.
  • Libby E; Royal North Shore Hospital, Sydney, NSW, Australia.
  • Matous JV; ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy.
  • Motta M; Bing Center for Waldenstrom Macroglobulinemia, Dana-Farber Cancer Institute, Boston, MA.
  • Siddiqi T; Department of Medicine, Harvard Medical School, Boston, MA.
  • Tani M; Szpital Uniwersytecki No 2 im Dr Jana Biziela, Bydgoszcz, Poland.
  • Trneny M; Department of Hematology, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Torun, Bydgoszcz, Poland.
  • Minnema MC; Amyloidosis and Myeloma Unit, Department of Hematology, Hospital Clinic of Barcelona, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.
  • Buske C; Fourth Department of Internal Medicine - Haematology, Charles University Hospital and Faculty of Medicine, Hradec Králové, Czech Republic.
  • Leblond V; Department of Medicine, University of Washington and the Seattle Cancer Care Alliance, Seattle, WA.
  • Trotman J; Colorado Blood Cancer Institute, Denver, CO.
  • Chan WY; ASST Spedali Civili di Brescia, Lombardia, Italy.
  • Schneider J; City of Hope National Medical Center, Duarte, CA.
  • Ro S; Ospedale Civile S Maria delle Croci, Azienda Unità Sanitaria Locale (AUSL), Ravenna, Italy.
  • Cohen A; First Department of Medicine, First Faculty of Medicine, Charles University, General Hospital, Prague, Czech Republic.
  • Huang J; University Medical Center Utrecht, Utrecht, The Netherlands.
  • Dimopoulos M; Comprehensive Cancer Center Ulm-Universitätsklinikum Ulm, Ulm, Germany.
Blood ; 136(18): 2038-2050, 2020 10 29.
Article in En | MEDLINE | ID: mdl-32731259
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antineoplastic Combined Chemotherapy Protocols / Waldenstrom Macroglobulinemia Type of study: Clinical_trials / Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Blood Year: 2020 Document type: Article Affiliation country: Australia Country of publication: Estados Unidos
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antineoplastic Combined Chemotherapy Protocols / Waldenstrom Macroglobulinemia Type of study: Clinical_trials / Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Blood Year: 2020 Document type: Article Affiliation country: Australia Country of publication: Estados Unidos